Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

Patrick Walsh

doi:10.1016/S0022-5347(01)68955-9

Phase I Trial of ¹⁷⁷Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	2223-2224
Number of pages	2
Journal	Journal of Urology
Volume	174
Issue number	6
DOIs	https://doi.org/10.1016/S0022-5347(01)68955-9
State	Published - Dec 1 2005
Externally published	Yes

ASJC Scopus subject areas

Urology

Access to Document

10.1016/S0022-5347(01)68955-9

Cite this

@article{037c18ed279e4e2b9686ce9a1e10dd67,

title = "Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer",

author = "Patrick Walsh",

year = "2005",

month = dec,

day = "1",

doi = "10.1016/S0022-5347(01)68955-9",

language = "English (US)",

volume = "174",

pages = "2223--2224",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

AU - Walsh, Patrick

PY - 2005/12/1

Y1 - 2005/12/1

UR - http://www.scopus.com/inward/record.url?scp=85028711590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028711590&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)68955-9

DO - 10.1016/S0022-5347(01)68955-9

M3 - Article

AN - SCOPUS:85028711590

SN - 0022-5347

VL - 174

SP - 2223

EP - 2224

JO - Journal of Urology

JF - Journal of Urology

IS - 6

ER -

Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Phase I Trial of ¹⁷⁷Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer